0
Abstract: Slide Presentations |

ECHOCARDIOGRAPHIC EVALUATION OF CARDIAC STRUCTURE AND FUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE FREE TO VIEW

Yunsu Sim, MD*
Author and Funding Information

Ewha Womans University, College of Medicine, Seoul, South Korea


Chest


Chest. 2007;132(4_MeetingAbstracts):427b. doi:10.1378/chest.132.4_MeetingAbstracts.427b
Text Size: A A A
Published online

Abstract

PURPOSE: In patients with chronic obstructive pulmonary disease (COPD), left ventricular (LV) systolic dysfunction and structural changes are known to be rare, while right ventricular (RV) dysfunction and structural alteration and/or LV diastolic dysfunction are common. We evaluated cardiac structure and function in COPD patients by using echocardiography.

METHODS: Echocardiographic examinations were performed in 69 patients with clinically stable COPD and without history of heart disease, and 23 control subjects with normal lung function. Echocardiographic parameters of COPD patients were compared with those of controls, and assessed according to COPD stage by using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria.

RESULTS: COPD patients had significantly lower body weight (p=0.002), and higher pack-years of smoking (p<0.001) and heart rate than controls (p=0.046). Echocardiogram showed that LV end diastolic diameter (p<0.001), LV end systolic diameter (p=0.032), left atrial (LA) diameter (p=0.020), and LV mass in COPD patients were significantly decreased as compared with controls (p=0.006). However, there was no difference between COPD patients and controls in the following parameters reflecting LV diastolic function; mitral flow velocity in early and late diastole E/A ratio, deceleration time, early diastole velocity of mitral annulus E’ measured by tissue Doppler echocardiography and E/E’ ratio. Mean RV systolic pressure (RVSP) of COPD patients was not significantly higher than controls. According to COPD stage, body weight (p<0.001), body mass index (BMI) (p<0.001), and LV mass were significantly different (p=0.011). Although patients with stage IV showed higher mean RVSP and more frequent pulmonary hypertension than patients with I, II, and III, they are not statistically significant. In COPD patients, LV mass (r=0.432) (p<0.001) and BMI significantly correlated with FEV1 % predicted (r=0.600) (p<0.001).

CONCLUSION: COPD patients showed lower LV mass and LA and LV diameters than controls, even though both groups had normal LV functions. In particular, LV mass was positively related to FEV1 in COPD.

CLINICAL IMPLICATIONS: LV mass appears to correlate with lung function. Further investigations focusing on its clinical significance are needed.

DISCLOSURE: Yunsu Sim, No Financial Disclosure Information; No Product/Research Disclosure Information

Monday, October 22, 2007

10:30 AM - 12:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543